Nuclear receptor coactivator
From Proteopedia
(Difference between revisions)
Line 17: | Line 17: | ||
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
+ | |||
[[1v95]] – hNCOA5 anticodon binding domain 197-313 – human - NMR<br /> | [[1v95]] – hNCOA5 anticodon binding domain 197-313 – human - NMR<br /> | ||
[[1kbh]], [[6es7]], [[6sqc]] – hNCOA3 1040-1086 + CREB-binding protein - NMR<br /> | [[1kbh]], [[6es7]], [[6sqc]] – hNCOA3 1040-1086 + CREB-binding protein - NMR<br /> |
Revision as of 09:39, 28 November 2021
|
3D structures of nuclear receptor coactivator
Updated on 28-November-2021
1v95 – hNCOA5 anticodon binding domain 197-313 – human - NMR
1kbh, 6es7, 6sqc – hNCOA3 1040-1086 + CREB-binding protein - NMR
2c52 – hNCOA1 residues 920-970 + CREB-binding protein - NMR
1oj5 – mNCOA1A Pas-B domain 257-367 + signal transducer and activator of transcription peptide - mouse
5y7w - mNCOA1A Pas-B domain + YL-2 peptide
References
- ↑ Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L. Nuclear receptor coactivators and corepressors. Mol Endocrinol. 1996 Oct;10(10):1167-77. PMID:9121485 doi:http://dx.doi.org/10.1210/mend.10.10.9121485